Search Results - "Mahon, Niall"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial by Sharif, Faisal, Rosenkranz, Stephen, Bartunek, Jozef, Kempf, Tibor, Assmus, Birgit, Mahon, Niall G., Mullens, Wilfried

    Published in ESC Heart Failure (01-10-2022)
    “…Aims Implantable pulmonary artery pressure (PAP) sensors have been shown to reduce heart failure hospitalizations (HFH) in selected patients. The goal of this…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Twelve‐month follow‐up results from the SIRONA 2 clinical trial by Sharif, Faisal, Rosenkranz, Stephen, Bartunek, Jozef, Kempf, Tibor, Aßmus, Birgit, Mahon, Niall G., Hiivala, Nicholas J., Mullens, Wilfried

    Published in ESC Heart Failure (01-04-2024)
    “…Aims In the SIRONA 2 trial, the safety and efficacy of pulmonary artery (PA) pressure (PAP)‐guided heart failure (HF) management using a novel PAP sensor were…”
    Get full text
    Journal Article
  9. 9

    A Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure by Roy, Andrew K., Mc Gorrian, Catherine, Treacy, Cecelia, Kavanaugh, Edel, Brennan, Alice, Mahon, Niall G., Murray, Patrick T.

    Published in Cardiorenal medicine (01-04-2013)
    “…Aims: To determine if newer criteria for diagnosing and staging acute kidney injury (AKI) during heart failure (HF) admission are more predictive of clinical…”
    Get full text
    Journal Article
  10. 10

    Family-based cardiac screening in relatives of victims of sudden arrhythmic death syndrome by McGorrian, Catherine, Constant, Orla, Harper, Nicola, O'Donnell, Catherine, Codd, Mary, Keelan, Edward, Green, Andrew, O'Neill, James, Galvin, Joseph, Mahon, Niall G

    Published in Europace (London, England) (01-07-2013)
    “…Sudden arrhythmic death syndrome (SADS) occurs when a person suffers a sudden, unexpected death, with no cause found at postmortem examination. We aimed to…”
    Get full text
    Journal Article
  11. 11

    Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy by Roy, Andrew K., McCarthy, Catherine, Kiernan, Gareth, McGorrian, Catherine, Keenan, Eamon, Mahon, Niall G., Sweeney, Brion

    Published in Addiction (Abingdon, England) (01-06-2012)
    “…ABSTRACT Aims  The aim of this study was to investigate the frequency of corrected QT interval (QTc) prolongation in a methadone maintenance therapy (MMT)…”
    Get full text
    Journal Article
  12. 12

    Sudden death in hypertrophic cardiomyopathy: identification of high risk patients by Elliott, Perry M, Poloniecki, Jan, Dickie, Shaughan, Sharma, Sanjay, Monserrat, Lorenzo, Varnava, Amanda, Mahon, Niall G, McKenna, William J

    “…OBJECTIVES We sought to identify patients with hypertrophic cardiomyopathy (HCM) at high risk of sudden death (SD). BACKGROUND Relatively low mortality rates…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Prospective familial assessment in dilated cardiomyopathy : Cardiac autoantibodies predict disease development in asymptomatic relatives by CAFORIO, Alida L. P, MAHON, Niall G, KAMRAN BAIG, M, TONA, Francesco, MURPHY, Ross T, ELLIOTT, Perry M, MCKENNA, William J

    Published in Circulation (New York, N.Y.) (02-01-2007)
    “…In autoimmune disorders, circulating autoantibodies identify healthy relatives at risk years before clinical presentation. Healthy relatives of patients with…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease by MAHON, Niall G, MURPHY, Ross T, MACRAE, Calum A, CAFORIO, Alida L. P, ELLIOTT, Perry M, MCKENNA, William J

    Published in Annals of internal medicine (19-07-2005)
    “…Idiopathic dilated cardiomyopathy is often familial, and apparently healthy relatives may have latent, early, or undiagnosed established disease. To determine…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance by Caforio, Alida L.P., Mahon, Niall J., Tona, Francesco, McKenna, William J.

    Published in European journal of heart failure (01-08-2002)
    “…Dilated cardiomyopathy (DCM) is a relevant cause of heart failure and a common indication for heart transplantation. It may be idiopathic, familial/genetic,…”
    Get full text
    Journal Article